多专业肿瘤学人员的阿片类药物风险缓解实践：横断面调查结果。

Opioid Risk Mitigation Practices of Interprofessional Oncology Personnel: Results From a Cross-Sectional Survey.

机构信息

Department of Nursing, James Cancer Hospital, The Ohio State University, Columbus, OH, USA.

Center for Biostatistics, The Ohio State University, Columbus, OH, USA.

出版信息

Oncologist. 2023 Nov 2;28(11):996-1004. doi: 10.1093/oncolo/oyad214.

DOI:10.1093/oncolo/oyad214

PMID:37498515

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10628582/

Abstract

BACKGROUND

This study explored the risk mitigation practices of multidisciplinary oncology health-care personnel for the nonmedical use of opioids in people with cancer.

METHODS

An anonymous, cross-sectional descriptive survey was administered via email to eligible providers over 4 weeks at The Ohio State University's Arthur G. James Cancer Hospital. The survey asked about experiences and knowledge related to opioid use disorders.

RESULTS

The final sample of 773 participants included 42 physicians, 213 advanced practice providers (APPs consisted of advanced practice nurses, physician assistants, and pharmacists), and 518 registered nurses. Approximately 40% of participants responded feeling "not confident" in addressing medication diversion. The most frequent risk reduction measure was "Checking the prescription drug monitoring program" when prescribing controlled medications, reported by physicians (n = 29, 78.4%) and APPs (n = 164, 88.6%).

CONCLUSION

People with cancer are not exempt from the opioid epidemic and may be at risk for nonmedical opioid use (NMOU) and substance use disorders. Implementing risk reduction strategies with every patient, with a harm reduction versus abstinence focus, minimizes harmful consequences and improves. This study highlights risk mitigation approaches for NMOU, representing an opportunity to improve awareness among oncology health-care providers. Multidisciplinary oncology teams are ideally positioned to navigate patients through complex oncology and health-care journeys.

摘要

背景

本研究探讨了多学科肿瘤医疗保健人员在癌症患者非医疗使用阿片类药物方面的风险缓解措施。

方法

在俄亥俄州立大学亚瑟·G·詹姆斯癌症医院，通过电子邮件向符合条件的医务人员进行了为期 4 周的匿名、横断面描述性调查。该调查询问了与阿片类药物使用障碍相关的经验和知识。

结果

最终的 773 名参与者样本包括 42 名医生、213 名高级实践提供者（高级实践护士、医生助理和药剂师）和 518 名注册护士。约 40%的参与者表示在解决药物滥用转移问题上“没有信心”。在开具管制药物时，最常见的降低风险措施是“检查处方药物监测计划”，医生（n=29，78.4%）和高级实践提供者（n=164，88.6%）都报告了这一点。

结论

癌症患者也不能免受阿片类药物流行的影响，他们可能有非医疗使用阿片类药物（NMOU）和药物使用障碍的风险。对每个患者实施风险缓解策略，以减少伤害而非戒除为重点，可以最大限度地减少有害后果并改善状况。本研究强调了 NMOU 的风险缓解方法，为提高肿瘤医疗保健提供者的意识提供了机会。多学科肿瘤团队最适合引导患者度过复杂的肿瘤和医疗保健之旅。